Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
1.050
-0.040 (-3.67%)
At close: Dec 5, 2025, 4:00 PM EST
1.020
-0.030 (-2.86%)
After-hours: Dec 5, 2025, 7:31 PM EST

Company Description

Basel Medical Group Ltd provides healthcare services in Singapore.

The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments.

It also provides health screening services, mental health, woman’s health, and general practice services.

In addition, its services include consultation, medical diagnosis, and medical and surgical treatments.

The company was incorporated in 2023 and is headquartered in Singapore.

Basel Medical Group Ltd
Basel Medical Group logo
Country Singapore
Founded 2001
IPO Date Feb 25, 2025
Industry Medical Care Facilities
Sector Healthcare
Employees 82
CEO Yen Feng Chhoa

Contact Details

Address:
Gleneagles Medical Centre, Unit No. 02-10/11
Singapore, 258499
Singapore
Phone 65 6291 9188
Website baselmedical.com

Stock Details

Ticker Symbol BMGL
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency SGD
IPO Price $4.00
CIK Code 0002004489
CUSIP Number G0864B103
ISIN Number VGG0864B1031
SIC Code 8011

Key Executives

Name Position
Dr. Yen Feng Chhoa M.D. Group Chief Health Officer and Interim Chief Executive Officer
Keng Leong Fung Executive Chairman of the Board
Jianing Lu Group Chief Financial Officer and Director
Boon Chye Tan Chief Commercial Officer

Latest SEC Filings

Date Type Title
Dec 1, 2025 6-K Report of foreign issuer
Nov 18, 2025 20-F Annual and transition report of foreign private issuers
Oct 27, 2025 NT 20-F Notification of inability to timely file Form 20-F
Aug 21, 2025 6-K Report of foreign issuer
Aug 13, 2025 6-K Report of foreign issuer
Jul 18, 2025 6-K Report of foreign issuer
Jul 2, 2025 6-K Report of foreign issuer
Jun 26, 2025 6-K Report of foreign issuer
Jun 18, 2025 6-K Report of foreign issuer
Jun 3, 2025 6-K Report of foreign issuer